A Phase I Trial of IMA970A Plus Montanide in Combination With Durvalumab (Anti-PD-L1)
Clinical trial NCT06218511 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06218511
- Sponsor
- National Cancer Institute, Naples
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-22
- Primary completion
- 2025-08-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.